Angela Beauchamp
Primary Care · Union, NJNPI 1265815385
Payments from drug & device makers
Across 119 payments — averaging $17.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$398
- Lilly USA, LLC$348
- Novo Nordisk$227
- GSK$160
- Pfizer$126
- AstraZeneca$107
- plus $660 from 16 others
What the payments were for
- Food & beverage$2,026100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 20 | $398 |
| Lilly USA, LLC | 23 | $348 |
| Novo Nordisk | 15 | $227 |
| GSK | 10 | $160 |
| Pfizer | 7 | $126 |
| AstraZeneca | 7 | $107 |
| Johnson & Johnson | 6 | $98 |
| AbbVie | 6 | $96 |
| Azurity Pharmaceuticals, Inc. | 5 | $90 |
| Otsuka America Pharmaceutical, Inc. | 5 | $75 |
| Atricure, Inc. | 2 | $71 |
| Dexcom, Inc. | 1 | $35 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Alk-abello, Inc | 1 | $21 |
| Biotronik NRO, Inc. | 1 | $21 |
| Biogen | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Merck | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
| Echosens North America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$125
How this compares
$2,026 in reported general payments places this provider in the 80th percentile of 330 primary care providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 20 | $25,680 |
| TrulicityDulaglutide | 12 | $24,799 |
| FarxigaDapagliflozin Propanediol | 12 | $16,236 |
| EliquisApixaban | 14 | $15,805 |
| OzempicSemaglutide | 16 | $14,920 |
| JanumetSitagliptin Phos/Metformin Hcl | 17 | $14,900 |
| Olmesartan Medoxomil | 24 | $1,419 |
| Rosuvastatin Calcium | 52 | $1,372 |
| Metoprolol Succinate | 42 | $842 |
| Atorvastatin Calcium | 111 | $734 |
| Fluticasone Propionate | 34 | $647 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 30 | $581 |
| Amlodipine Besylate | 72 | $335 |
| Losartan Potassium | 49 | $335 |
| Metformin Hcl | 46 | $321 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $398 | $25,68020 claims |
| Lilly USA, LLCTrulicity | $348 | $24,79912 claims |
| AstraZenecaFarxiga | $107 | $16,23612 claims |
| PfizerEliquis | $126 | $15,80514 claims |
| Novo NordiskOzempic | $227 | $14,92016 claims |
| MerckJanumet | $15 | $14,90017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 330 primary care providers in New Jersey.
Other primary care in Union
- Michael Zito GovertNeptune$61K
- Roseann BenantiEnglewood$24K
- Marcelo MarinEnglewood$17K
- Jennifer EdwardsPrinceton$14K
- Mary Grace TolentinoJersey City$9K
- Kevin Robert ReyladoNorth Arlington$8K
- Carlo SebelloJersey City$8K
- Karam WehbehPaterson$7K
- Shazam BacchusNewark$7K
- Anna NievesBasking Ridge$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.